Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

  • 00:29

    Jonathan Sandlund of The Crowd Cafe

    in Business

    Host Doug Atkin interviews The Crowd Cafe's Jonathan Sandlund

  • 00:14

    Crowd Funding Terms

    in Business

    Are you confused by all the different crowd funding terms you hear thrown around? After today's show you will be clear on what's what!
    Our featured project is the Flamio lamp
    Learn more at Get Crowd Funded Now

  • 00:01

    Crowd funding Your business

    in Business

    Dr. Wright talks about crowd funding success and 
    the To Proove Him Wrong Campaign at

  • 01:08
  • 01:10

    Myeloma Crowd Radio/MCRI: Dr. Guenther Koehne, MD, PhD, MSKCC

    in Health

    Join us for our second interview on Myeloma Crowd Radio highlighting the new Myeloma Crowd Research Initiative on high-risk myeloma. As part of this series, Dr. Guenther Koehne, MD, PhD of the Memorial Sloan Kettering Cancer Center will share his use of a T cell vaccine with an allogeneic transplant to provide outstanding results, even in plasma leukemia patients. His research pulls out T cells, marks them with a tag to target the WT1 protein, and are given back. He will describe how this works, the impact he has seen so far, the stage of his clinical trial and the work left to do to make this an available therapy for high-risk myeloma patients. 

    Dr. Guenther Kohene, MD, PhD is Medical Director of the Cell Therapy Laboratory in the Bone Marrow Transplantation Laboratory at Sloan Kettering. He is also Assistant Member and Assistant Attending Physician in the Allogeneic Bone Marrow Transplantation Service. He is Assistant Professor of the Joan and Sanford Weill Medical College of Cornell University. He leads research at the BMT Department/Immunology Program to develop adoptive immunotherapeutic strategies for post-transplant blood disorders. He has particular expertise in the creation and monitoring of antigen-specific T cell responses in these patients. He is the Principal Investigator in active clinical trials using adoptive cell therapy following allogeneic stem cell transplants for multiple myeloma and plasma cell leukemia patients. He obtained his medical degree at the University of Hamburg, Germany and has been at Memorial Sloan Kettering Cancer Center permanently since 2005.

    Special thanks to our Myeloma Crowd Radio Episode sponsor, Takeda Oncology.

  • 00:15

    Success Strategies for Crowd Funding

    in Business

    Dr. Wright will discuss 2 strategies for successful crowd funding and will feature a new project called  JR Terrier Books  


     Get this months bonus package - Trinity Productivity Sheet

     and make 3x as much money  at Get Crowd Funded Now 

  • 00:12

    Illegal crowd funding projects

    in Business

      Dr. Wright talks about illegal crowd funding and shows an example of how NOT to set up your crowd funding project. 
    Get on the mailing list at www.getcrowdfundednow.com 

  • 01:25

    Myeloma Crowd Radio: Dr. Kenneth Anderson, MD, PhD, Dana-Farber Cancer Institute

    in Health

    The advances found for multiple myeloma over the past two decades have been extroardinary. Much has been learned, and much has been accomplished with new treatment developments and arguably more discoveries than other cancers in the same time period. The past is impressive for this complex cancer, but there is more work to do. Dr. Ken Anderson helped lead the way for the discovery of new developments over a prestigious career of 40 years. He shares with us a brief look back and what he sees for the road ahead towards a cure.

    Dr. Anderson is the Kraft Family Professor of Medicine at Harvard Medical School as well as Director of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. He is a Doris Duke Distinguished Clinical Research Scientist and American Cancer Society Clinical Research Professor. After graduating from Johns Hopkins Medical School, he trained in internal medicine at John’s Hopkins Hospital, and then completed hematology, medical oncology, and tumor immunology training at the Dana-Farber Cancer Institute. Over the last three decades, he has focused his laboratory and clinical research studies on multiple myeloma. He has developed laboratory and animal models of the tumor in it is microenvironment which have allowed for both identification of novel targets and validation of novel targeted therapies, and has then rapidly translated these studies to clinical trials culminating in FDA approval of novel targeted therapies. His paradigm for identifying and validating targets in the tumor cell and its milieu has transformed myeloma therapy and markedly improved patient outcome. 

    Thanks to our episode sponsor, Takeda Oncology

  • 00:16

    Join The Crowd for a discussion with Clark Musser of Dauntless Software

    in News

    Dauntless Software is taking their technology to the masses with a Indiegogo Crowdfunding Campaign.

    Tracing the World's Food Supply with NFC Smart Phones

    We will develop the software and services needed to simplify the automation of tracking a supply chain from point of origin to the moment of consumption

    The Project...

    Traceability. This is a key word in the world-wide effort of ensuring the food we are eating is fresh, safe, and supplied by reputable farms. When we know where our food is coming from, we can keep the farmer and supply chain accountable to meet or exceed governmental standards against substandard crops and food borne diseases.

    And what happens when a pathogen is found in our supply? With traceability, we will know which products to pull, which supply chain to check, and which farms to address.

    Some traceability exists today but new regulations are taking effect that are pushing the supply chains toward a more granular understanding of where our food comes from and where it is going.

    Join us Today at 5:30 Pacific Time for a Question and Answer Session with The Crowd

    For more about Dauntless Software please visit https://www.indiegogo.com/projects/tracing-the-world-s-food-supply-with-nfc-smart-phones/x/1174327

  • 00:01

    Crowd Funding Basics

    in Business

    Dr. Wright talk about how crowd funding can fund your dreams
    Fashion Collaboration Platform Features Fashion Inspirta

  • 01:06

    Myeloma Crowd Radio: Dr. Tomer Mark, MD, MSc, Weill Cornell Medical Center

    in Health

    Treatment for multiple myeloma is all about the combinations. Recently we've been hearing about the "BIRD" combinations. What are they and how effective are they? Learn from Dr. Tomer Mark, MD, MSc from Weill Cornell Medical Center about this new combination and what it means for myeloma patients.